The Minnetonka and Edina Girls Basketball teams are rivals on the court, but now they are joining forces to defeat a common ...

Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help ...

The menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women, according to a ...

For patients with newly diagnosed multiple myeloma (NDMM) receiving dexamethasone induction, dose reductions do not ...

The PoNS device led to sustained benefits in gait function in people with multiple sclerosis in a real-world study.

Researchers identified a key protein as a potential therapeutic target for stopping the body's immune system from mistakenly attacking itself, offering new hope for treating autoimmune diseases and ...

The number of people living with neurological disorders, such as Alzheimer’s disease, epilepsy, multiple sclerosis and Parkinson’s disease, has increased as the population has aged. At the same time, ...

MS patients who achieve long-term stable disease on disease-modifying therapy may want to stop their medication for varying ...

FDA issues new warnings about rare but severe allergic reactions, including anaphylaxis, linked to MS drug glatiramer acetate, urging immediate medical attention.

Mothers with multiple sclerosis (MS) have an elevated incidence and prevalence of peripartum mental illness, accordi ...

Overall, women with MS have a 26% increased risk of mental illness during pregnancy and a 33% increased risk after giving birth, compared to women without the degenerative nerve disease.

People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other chronic conditions, according to a new study analyzing over 890,000 births ...